Recent News

• 10.22.2026 - Upcoming Webinar: De-Risking Cell & Gene Therapy Development With Integrated Laboratory Expertise
• 10.19.2026 - Medpace Recognized as CRO Recipient of the 2026 SCRS Eagle Award
• 10.14.2026 - Behind the Breakthroughs: Rare Disease Q&A with Catalina Olano-Marín
• 10.13.2026 - Q&A With Psychiatry Specialist Dr. James Xidas
• 10.12.2026 - Upcoming Webinar: Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
• 10.08.2026 - Respiratory Innovation Moves Closer to Disease Modification
• 10.02.2026 - GAMRIC 2026 Recap: Advancing the Fight Against Antimicrobial Resistance (AMR)
• 10.02.2026 - Overcoming the Greatest Barriers in Rare Disease Patient Recruitment
• 09.30.2026 - Upcoming Webinar: Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight
• 09.15.2026 - Supporting Complex Phase I Studies Through Integrated Imaging and Specialized Assessments

Recent Filings

• 10.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.22.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.21.2026 - 8-K Current report
• 10.21.2026 - EX-99.1 EX-99.1
• 10.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.01.2026 - 4 Statement of changes in beneficial ownership of securities